Display options
Cite
David FJ, Munoz MJ, Shils JL, et al. Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study. Front Neurol. 2021;12:723476doi: 10.3389/fneur.2021.723476.
David, F. J., Munoz, M. J., Shils, J. L., Pauciulo, M. W., Hale, P. T., Nichols, W. C., Afshari, M., Sani, S., Verhagen Metman, L., Corcos, D. M., & Pal, G. D. (2021). Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study. Frontiers in neurology, 12723476. https://doi.org/10.3389/fneur.2021.723476
David, Fabian J, et al. "Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study." Frontiers in neurology vol. 12 (2021): 723476. doi: https://doi.org/10.3389/fneur.2021.723476
David FJ, Munoz MJ, Shils JL, Pauciulo MW, Hale PT, Nichols WC, Afshari M, Sani S, Verhagen Metman L, Corcos DM, Pal GD. Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study. Front Neurol. 2021 Sep 30;12:723476. doi: 10.3389/fneur.2021.723476. eCollection 2021. PMID: 34659089; PMCID: PMC8514636.
Copy Download .nbib Format: NLM
Share it on

Front Neurol. 2021 Sep 30;12:723476. doi: 10.3389/fneur.2021.723476. eCollection 2021.

Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study.

Frontiers in neurology

Fabian J David, Miranda J Munoz, Jay L Shils, Michael W Pauciulo, Philip T Hale, William C Nichols, Mitra Afshari, Sepehr Sani, Leo Verhagen Metman, Daniel M Corcos, Gian D Pal

Affiliations

  1. Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL, United States.
  2. Department of Anesthesiology, Rush University Medical Center, Chicago, IL, United States.
  3. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
  4. Department of Neurological Science, Rush University Medical Center, Chicago, IL, United States.
  5. Department of Neurosurgery, Rush University Medical Center, Chicago, IL, United States.
  6. Department of Neurology, Rutgers University, New Brunswick, NJ, United States.

PMID: 34659089 PMCID: PMC8514636 DOI: 10.3389/fneur.2021.723476

[No abstract available.]

Copyright © 2021 David, Munoz, Shils, Pauciulo, Hale, Nichols, Afshari, Sani, Verhagen Metman, Corcos and Pal.

Keywords: GBA mutation carriers; Parkinson's disease; deep brain stimulation; local field potential (LFP); subthalamic nucleus beta power

Conflict of interest statement

FD and MM received grant support from NIH. JS receives consulting fees from Medtronic. SS received grant support from NIH, Medtronic, Abbott, and Boston Scientific. LV has research support from Michae

References

  1. J Physiol. 2005 Oct 15;568(Pt 2):699-711 - PubMed
  2. Comput Intell Neurosci. 2011;2011:156869 - PubMed
  3. Exp Neurol. 2009 Feb;215(2):380-7 - PubMed
  4. Biosens Bioelectron. 2021 Mar 15;176:112888 - PubMed
  5. PLoS One. 2013 Jul 23;8(7):e69190 - PubMed
  6. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 - PubMed
  7. Neurobiol Dis. 2020 Dec;146:105090 - PubMed
  8. PLoS One. 2020 Jan 24;15(1):e0226494 - PubMed
  9. Hum Brain Mapp. 2017 Jul;38(7):3377-3390 - PubMed
  10. Ann Neurol. 2016 Nov;80(5):662-673 - PubMed
  11. J Clin Neurosci. 2017 Jun;40:130-135 - PubMed
  12. J Neurol Neurosurg Psychiatry. 2011 May;82(5):569-73 - PubMed
  13. Clin Neurophysiol. 2005 Nov;116(11):2510-9 - PubMed
  14. Exp Neurol. 2010 Nov;226(1):120-7 - PubMed
  15. J Neurosci. 2008 Jun 11;28(24):6165-73 - PubMed
  16. Mov Disord. 2015 Dec;30(14):1967-70 - PubMed
  17. N Engl J Med. 2009 Oct 22;361(17):1651-61 - PubMed
  18. Mov Disord Clin Pract. 2016 Sep-Oct;3(5):465-471 - PubMed
  19. Eur J Neurosci. 2021 Apr;53(8):2804-2818 - PubMed
  20. JAMA Netw Open. 2019 Feb 1;2(2):e187800 - PubMed
  21. Neuroimage Clin. 2017 Feb 12;14:433-440 - PubMed
  22. Parkinsonism Relat Disord. 2020 Jul;76:56-62 - PubMed
  23. Brain. 2016 May;139(Pt 5):1482-96 - PubMed
  24. Mov Disord Clin Pract. 2019 Jun 19;6(5):359-368 - PubMed
  25. Mov Disord. 2013 Sep;28(10):1370-5 - PubMed
  26. Parkinsonism Relat Disord. 2021 Jul;88:51-57 - PubMed
  27. Eur J Neurosci. 2006 Apr;23(7):1956-60 - PubMed
  28. Neuromodulation. 2017 Jan;20(1):15-30 - PubMed
  29. Bioinformatics. 2004 Jan 1;20(1):5-20 - PubMed
  30. Mov Disord. 2002;17 Suppl 3:S15-21 - PubMed
  31. Mov Disord. 2008 Nov 15;23(15):2129-70 - PubMed
  32. Exp Neurol. 2012 Oct;237(2):312-7 - PubMed
  33. Brain Stimul. 2012 Jul;5(3):378-387 - PubMed
  34. Biophys Chem. 2021 Jun;273:106534 - PubMed
  35. Stereotact Funct Neurosurg. 2018;96(4):231-238 - PubMed
  36. J Clin Neurosci. 2018 Apr;50:58-61 - PubMed
  37. J Neurol. 2020 Apr;267(4):883-897 - PubMed
  38. J Neurosci. 2014 Apr 30;34(18):6273-85 - PubMed
  39. Mov Disord. 2020 Nov;35(11):2111-2114 - PubMed
  40. Neurology. 2009 Jan 27;72(4):310-6 - PubMed
  41. Exp Brain Res. 2020 Aug;238(7-8):1659-1676 - PubMed
  42. J Neurosci Methods. 2004 Mar 15;134(1):9-21 - PubMed

Publication Types

Grant support